Laguna Pharmaceuticals

With $40m in Series A cash and led by a new, experienced executive team, Cirius Therapeutics Inc. is expanding a Phase IIb dose-finding trial of its insulin sensitizer MSDC-0602K in non-alcoholic st

New At The Helm Company Changes ATKINSON , James To: Viveve Medical Inc. , CBO & Pres. (February) From: Ulthera Inc., SVP, Global Sales Phone: 408-530-1900 BALKOVEC , James To: Cidara Thera

IN VITRO DIAGNOSTICS ACT Genomics Co. Ltd. ACT Genomics raises $8mm in Series A round Molecular diagnostics start-up ACT Genomics Co. Ltd. raised $8mm in Series A funding from undisclosed new

With an immediate goal of repeating the efficacy and safety findings of a Phase IIb trial in atrial fibrillation, Laguna Pharmaceuticals Inc. plans to initiate a Phase III trial of its re-purposed